Tag Archives: Partner Fund Management

← Older posts

Shattuck Labs Nabs $118M for Cancer Drugs Like Keytruda, But Better

Checkpoint inhibitors do one thing: release the molecular brake that keeps immune cells from recognizing and targeting tumors. This cancer immunotherapy approach has saved countless lives and turned drugs from Merck and Bristol Myers Squibb into blockbuster products. But what if a single drug could block checkpoint proteins while simultaneously sparking an anti-tumor response? That’s […]

Posted in Boston blog main, Boston top stories, Europe blog main, Europe top stories, National blog main, New York blog main, New York top stories, Raleigh-Durham, Raleigh-Durham blog main, Raleigh-Durham top stories, San Francisco blog main, San Francisco top stories, Seattle blog main, Seattle top stories | Tagged , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , | Comments Off on Shattuck Labs Nabs $118M for Cancer Drugs Like Keytruda, But Better

Avidity Bio Adds $100M to Advance R&D of Muscle Disorder Drugs

Earlier this year, Avidity Biosciences and Eli Lilly began a partnership to develop new drugs based on the biotech’s technology for delivering genetic material to cells. On Wednesday, Lilly was among a group of investors that joined a $100 million financing for the company. The funding, a Series C round, was led by RTW Investments. […]

Posted in Indiana blog main, Indiana top stories, National blog main, San Diego, San Diego blog main, San Diego top stories | Tagged , , , , , , , , , , , , , , , , , , , , , , , , | Comments Off on Avidity Bio Adds $100M to Advance R&D of Muscle Disorder Drugs

Auris Health Lands $220M to Expand Sales of Lung Testing Medical Robot

Auris Health has already received regulatory clearance to sell its medical robot in the U.S. Now it has $220 million in funding to help it place the technology in the hands of surgeons. The latest investment, which the company calls “growth financing,” was led by Partner Fund Management. Redwood City, CA-based Auris says it will […]

Posted in National blog main, San Francisco, San Francisco blog main, San Francisco top stories | Tagged , , , , , , , , , , , , , , , , , , , , | Comments Off on Auris Health Lands $220M to Expand Sales of Lung Testing Medical Robot

Anti-Aging Startup Unity Bio Grabs $55M, Plans First Clinical Trial

[Updated, 3/19/18, 6:32 p.m. See below.] Unity Biotechnology is trying to treat age-related diseases where it says many of them start: the production of the cellular proteins that lead to the deterioration associated with age. The startup is gearing up to test its first drug in humans and it now has $55 million to back […]

Posted in National blog main, San Francisco, San Francisco blog main, San Francisco top stories | Tagged , , , , , , , , , , , , , , , , , , , | Comments Off on Anti-Aging Startup Unity Bio Grabs $55M, Plans First Clinical Trial

Neon Therapeutics Garners $70,000,000 Series B Round

Feed Type Link http://www.venturedeal.com/Search/SearchResultTransactionDetail.aspx?TransactionId=1676734f-3acc-487c-b243-0435ea2abc54 Date 1/6/2017 Company Name Neon Therapeutics Mailing Address 215 First Street Cambridge, MA 02142 USA Company Description We have assembled a team of world experts in cancer immunotherapy to develop therapies that target abnormal proteins called neoantigens, which are produced by cancer cells. Website http://www.neontherapeutics.com Transaction Type Venture Equity Transaction Amount […]

Posted in Boston, Boston VentureDeal VC | Tagged , , , , , , , | Comments Off on Neon Therapeutics Garners $70,000,000 Series B Round

Neon Therapeutics Hauls in $70M for Personalized Cancer Vaccines

One of the challenges of enlisting the body’s immune system to fight cancer is the constant mutation of the disease. If the body’s immune cells don’t recognize the cancer, they can’t target tumors effectively. Neon Therapeutics believes it has developed a way to make cancer vaccines that recognize and respond to these tumor changes. Now […]

Posted in Boston, Boston blog main, Boston top stories, National blog main, San Francisco blog main | Tagged , , , , , , , , , , , , , , , | Comments Off on Neon Therapeutics Hauls in $70M for Personalized Cancer Vaccines

UNITY Biotechnology Lands $116,000,000 Series B Funding

Feed Type Link http://www.venturedeal.com/Search/SearchResultTransactionDetail.aspx?TransactionId=5038dcbf-79a0-4e40-aaf0-61e671bdb213 Date 10/31/2016 Company Name UNITY Biotechnology Mailing Address 1700 Owens Street San Francisco, CA 94158 USA Company Description Imagine a future in which you age, but without the diseases your parents got. A future in which it doesn’t hurt to grow old. At UNITY, we design therapeutics that prevent, halt, or […]

Posted in San Francisco, San Francisco VentureDeal VC | Tagged , , , , , , , , , | Comments Off on UNITY Biotechnology Lands $116,000,000 Series B Funding

Sienna Biopharmaceuticals Garners $12,000,000 Series A Financing

Feed Type Link http://www.venturedeal.com/Search/SearchResultTransactionDetail.aspx?TransactionId=b7c065d5-79c8-4ee0-8187-3037bdb933e2 Date 7/13/2016 Company Name Sienna Biopharmaceuticals Mailing Address 30721 Russell Ranch Road Westlake Village, CA 91362 USA Company Description Sienna Biopharmaceuticals is a company focused on the discovery, clinical development and commercialization of products in aesthetics and dermatology based on scientific breakthroughs that dramatically improve patient outcomes and physicians’ practice of […]

Posted in San Diego, San Diego VentureDeal VC | Tagged , , , , | Comments Off on Sienna Biopharmaceuticals Garners $12,000,000 Series A Financing

Sienna Biopharmaceuticals Secures $34,000,000 Series A Funding Round

Feed Type Link http://www.venturedeal.com/Search/SearchResultTransactionDetail.aspx?TransactionId=34b4b8aa-2dc8-48b6-9b66-3e335e894adb Date 4/30/2016 Company Name Sienna Biopharmaceuticals Mailing Address 30721 Russell Ranch Road Westlake Village, CA 91362 USA Company Description Sienna Biopharmaceuticals is a company focused on the discovery, clinical development and commercialization of products in aesthetics and dermatology based on scientific breakthroughs that dramatically improve patient outcomes and physicians’ practice of […]

Posted in San Diego, San Diego VentureDeal VC | Tagged , , , , , | Comments Off on Sienna Biopharmaceuticals Secures $34,000,000 Series A Funding Round

East Coast Biotech Roundup: ASH, Kallyope, SQZ, Kyras & More

Boston and New York are known for their sports rivalries, particularly the century-old blood feud between the Yankees and Red Sox. As locals know, for most of that time, Yankees-Red Sox wasn’t much of a rivalry. The mythical “Curse of the Bambino” ensured the Yankees were the hammer, and the Red Sox the nail—until a […]

Posted in Boston, Boston blog main, National blog main, New York blog main, New York top stories | Tagged , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , | Comments Off on East Coast Biotech Roundup: ASH, Kallyope, SQZ, Kyras & More← Older posts